NCT05699993

A Study of IBI351 in Healthy Subjects

An Open-label, 2-cycle Clinical Study to Evaluate the Drug Interaction Between Itraconazole or Dextromethorphan and IBI351 in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Innovent Biologics (Suzhou) Co. Ltd. · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This is an open-label, two-cycle clinical study to evaluate the drug interaction between itraconazole or dextromethorphan and IBI351 in healthy subjects. A total of two cohorts of 12 healthy male subjects were planned to be enrolled in each cohort.

Conditions

• Healthy Subjects

Interventions

Type	Name	Description
DRUG	Itraconazole	Itraconazole was administered orally
DRUG	IBI351	IBI351 was administered orally
DRUG	Dextromethorphan	Dextromethorphan was administered orally

Timeline

• Start date: 2023-03-10
• Primary completion: 2023-10-16
• Completion: 2023-10-16
• First posted: 2023-01-26
• Last updated: 2023-10-24

Locations

1 site across 1 country: China